top of page

NDC | HCPCS | HCPCS Description | NDC Label | Route of Administration |
|---|---|---|---|---|
50742-0512-20 | J9027 | INJECTION, CLOFARABINE, 1 MG | CLOFARABINE (SDV,PF) 1 MG/1 ML | IV |
50742-0519-02 | J9070 | CYCLOPHOSPHAMIDE, 100 MG | CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML | IV |
50742-0520-05 | J9070 | CYCLOPHOSPHAMIDE, 100 MG | CYCLOPHOSPHAMIDE (PF) 200 MG/1 ML | IV |
50742-0521-10 | J9070 | CYCLOPHOSPHAMIDE, 100 MG | CYCLOPHOSPHAMIDE (MDV) 200 MG/1 ML | IV |
50881-0006-03 | J9345 | INJECTION, RETIFANLIMAB-DLWR, 1 MG | ZYNYZ (SDV,PF) 25 MG/1 ML | IV |
59353-0004-01 | Q5106 | INJECTION, EPOETIN ALFA, BIOSIMILAR, (RETACRIT) (FOR NON-ESRD USE), 1000 UNITS | RETACRIT (PF) 4000 U/1 ML | IJ |
59353-0004-10 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | RETACRIT (PF) 4000 U/1 ML | IJ |
59353-0004-10 | Q5106 | INJECTION, EPOETIN ALFA, BIOSIMILAR, (RETACRIT) (FOR NON-ESRD USE), 1000 UNITS | RETACRIT (PF) 4000 U/1 ML | IJ |
59353-0010-01 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | RETACRIT (PF) 10000 U/1 ML | IJ |
59353-0010-01 | Q5106 | INJECTION, EPOETIN ALFA, BIOSIMILAR, (RETACRIT) (FOR NON-ESRD USE), 1000 UNITS | RETACRIT (PF) 10000 U/1 ML | IJ |
59353-0010-10 | J0885 | INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS | RETACRIT (PF) 10000 U/1 ML | IJ |
59353-0010-10 | Q5106 | INJECTION, EPOETIN ALFA, BIOSIMILAR, (RETACRIT) (FOR NON-ESRD USE), 1000 UNITS | RETACRIT (PF) 10000 U/1 ML | IJ |
HCPCS Code | Description | Billing Unit | SA Type |
|---|---|---|---|
A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | Each | N |
A7006 | Administration set, with small volume filter pneumatic nebulizer | Each | N |
A7007 | Large voume nebulizer, disposable, unfilled, used with aerosol compressor | Each | N |
A7008 | Large volume nebulizer, disposable, Prefilled, used with aerosol compressor | Each | N |
bottom of page
